These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1794787

  • 1. [Analysis of the protein pattern in physiologic and pathologic vitreous bodies by electrophoresis and immunologic identification].
    Bresgen M, Martiny B, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1991; 88(6):665-70. PubMed ID: 1794787
    [Abstract] [Full Text] [Related]

  • 2. [Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis].
    Bresgen M, Baum U, Esser P, Wiedemann P, Heimann K.
    Ophthalmologe; 1994 Dec; 91(6):758-62. PubMed ID: 7849428
    [Abstract] [Full Text] [Related]

  • 3. [Isoelectric focusing and electroblotting of human vitreous body proteins].
    Moter H, Wiedemann P, Weller M, Heimann K.
    Fortschr Ophthalmol; 1989 Dec; 86(4):399-402. PubMed ID: 2793016
    [Abstract] [Full Text] [Related]

  • 4. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
    Clausen R, Weller M, Hilgers RD, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Dec; 87(3):283-6. PubMed ID: 2376377
    [Abstract] [Full Text] [Related]

  • 5. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Dec; 87(3):279-82. PubMed ID: 2198204
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
    Kim SJ, Kim S, Park J, Lee HK, Park KS, Yu HG, Kim Y.
    Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
    [Abstract] [Full Text] [Related]

  • 7. Identification of phosphotyrosyl proteins in vitreous humours of patients with vitreoretinal diseases by sodium dodecyl sulphate-polyacrylamide gel electrophoresis/Western blotting/matrix-assisted laser desorption time-of-flight mass spectrometry.
    Mukai N, Nakanishi T, Shimizu A, Takubo T, Ikeda T.
    Ann Clin Biochem; 2008 May; 45(Pt 3):307-12. PubMed ID: 18482920
    [Abstract] [Full Text] [Related]

  • 8. Identification and localization of major soluble vitreous proteins in human ocular tissue.
    Wu CW, Sauter JL, Johnson PK, Chen CD, Olsen TW.
    Am J Ophthalmol; 2004 Apr; 137(4):655-61. PubMed ID: 15059704
    [Abstract] [Full Text] [Related]

  • 9. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].
    Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, Pfeiffer A.
    Med Klin (Munich); 1995 Mar 01; 90(3):134-7. PubMed ID: 7723714
    [Abstract] [Full Text] [Related]

  • 10. Analysis of age-related carbonylation of human vitreous humor proteins as a tool for forensic diagnosis.
    Kumagai A, Nakayashiki N, Aoki Y.
    Leg Med (Tokyo); 2007 Jul 01; 9(4):175-80. PubMed ID: 17307013
    [Abstract] [Full Text] [Related]

  • 11. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1991 Jul 01; 88(4):337-40. PubMed ID: 1786916
    [Abstract] [Full Text] [Related]

  • 12. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
    Sánchez MC, Luna JD, Barcelona PF, Gramajo AL, Juarez PC, Riera CM, Chiabrando GA.
    Exp Eye Res; 2007 Nov 01; 85(5):644-50. PubMed ID: 17826767
    [Abstract] [Full Text] [Related]

  • 13. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
    Macha S, Mitra AK.
    Exp Eye Res; 2001 Mar 01; 72(3):289-99. PubMed ID: 11180978
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J, Oficjalska-Młyńczak J.
    Przegl Lek; 2007 Mar 01; 64(6):389-92. PubMed ID: 18159844
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Müller glial cells--the mediators of vascular disorders with vitreomacular interface pathology in diabetic maculopathy.
    Robaszkiewicz J, Chmielewska K, Figurska M, Wierzbowska J, Stankiewicz A.
    Klin Oczna; 2010 Mar 01; 112(10-12):328-32. PubMed ID: 21469528
    [Abstract] [Full Text] [Related]

  • 19. Retinal breaks in diabetic retinopathy: vitreoretinal relationships.
    Kakehashi A, Trempe CL, Fujio N, McMeel JW, Schepens CL.
    Ophthalmic Surg; 1994 Mar 01; 25(10):695-9. PubMed ID: 7898863
    [Abstract] [Full Text] [Related]

  • 20. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct 01; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.